The University of Queensland

Frailty Index, Not Age, Predicts Treatment Outcomes and Adverse Events for Older Adults with Cancer

Fletcher, J., Reid, N., Hubbard, R.E., Berry, R., Weston, M., Walpole, E., Kimberley, R., Thaker, D.A. and Ladwa, R. (2024). Frailty Index, Not Age, Predicts Treatment Outcomes and Adverse Events for Older Adults with Cancer. Journal of Frailty & Aging, 1-8. doi: 10.14283/jfa.2024.22

EP08.02-02 Real World Chemoradiotherapy Outcomes for Frail Older Adults with Unresectable Stage III Non Small Cell Lung Cancer (NSCLC)

Fletcher, J., Pringle, N., Mullally, W., O'Byrne, K., Xu, W. and Ladwa, R. (2023). EP08.02-02 Real World Chemoradiotherapy Outcomes for Frail Older Adults with Unresectable Stage III Non Small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology, 18 (11), S568. doi: 10.1016/j.jtho.2023.09.1066

EP08.02-03 Real World Experience of Survival Outcomes in Consolidative Durvalumab in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)

Pringle, N., Fletcher, J.A., Morton, C., Mullally, W.J., Arneil, M., O'Byrne, K. and Xu, W. (2023). EP08.02-03 Real World Experience of Survival Outcomes in Consolidative Durvalumab in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology, 18 (11), S569. doi: 10.1016/j.jtho.2023.09.1067

EP11.03-20 Real World Experience of First Line Pembrolizumab for Non-Small Cell Lung Cancer (NSCLC) at a Tertiary Centre

Fletcher, J., Mullally, W.J., Berman, C., Ladwa, R., Xu, W. and O'Byrne, K. (2023). EP11.03-20 Real World Experience of First Line Pembrolizumab for Non-Small Cell Lung Cancer (NSCLC) at a Tertiary Centre. Journal of Thoracic Oncology, 18 (11), S628-S629. doi: 10.1016/j.jtho.2023.09.1192

Lorlatinib following alectinib-induced pneumonitis: A case report

Fletcher, James A., Mullally, William J., Ladwa, Rahul and O’Byrne, Kenneth J. (2023). Lorlatinib following alectinib-induced pneumonitis: A case report. JTO Clinical and Research Reports, 5 (2) 100591, 100591. doi: 10.1016/j.jtocrr.2023.100591

How frail is frail in oncology studies? A scoping review

Fletcher, James A., Logan, Benignus, Reid, Natasha, Gordon, Emily H., Ladwa, Rahul and Hubbard, Ruth E. (2023). How frail is frail in oncology studies? A scoping review. BMC Cancer, 23 (1) 498, 498. doi: 10.1186/s12885-023-10933-z

Administration of immune checkpoint inhibitors at rural towns using the Teleoncology model of care—A North Queensland perspective

Kang, Sebastian, Fletcher, James, Htut, Saw, Brown, Amy, Lyle, Megan, Sabesan, Sabe and Joshi, Abhishek (2023). Administration of immune checkpoint inhibitors at rural towns using the Teleoncology model of care—A North Queensland perspective. Australian Journal of Rural Health, 31 (3), 540-545. doi: 10.1111/ajr.12984

Acquired haemophilia A secondary to an immune checkpoint inhibitor: a case report

Fletcher, James, Bird, Robert, McLean, Andrew J. W., O’Byrne, Kenneth and Xu, Wen (2022). Acquired haemophilia A secondary to an immune checkpoint inhibitor: a case report. JTO Clinical and Research Reports, 3 (11) 100409, 1-6. doi: 10.1016/j.jtocrr.2022.100409

The impact of frailty on health outcomes in older adults with lung cancer: a systematic review

Fletcher, James, Fox, Sarah, Reid, Natasha, Hubbard, Ruth E. and Ladwa, Rahul (2022). The impact of frailty on health outcomes in older adults with lung cancer: a systematic review. Cancer Treatment and Research Communications, 33 100652, 1-10. doi: 10.1016/j.ctarc.2022.100652

Extracellular Small Vesicle Phosphorylated PD-L1 Liquid Biopsy Levels Correlate with Tumour Proportion Score (TPS) in NSCLC

O'Byrne, K., Shanmugasundaram, K.B., Ahmed, E., Kulasinghe, A., Monkman, J., Fletcher, J.A., Mainwaring, P.N., Masud, M.K., Park, H., Hossain, M.S.A., Yamauchi, Y., Sina, A.A.I., Wuethrich, A. and Trau, M. (2023). Extracellular Small Vesicle Phosphorylated PD-L1 Liquid Biopsy Levels Correlate with Tumour Proportion Score (TPS) in NSCLC. 2023 World Conference on Lung Cancer, Singapore, 9-12 September 2023. New York, NY United States: Elsevier. doi: 10.1016/j.jtho.2023.09.432

Retrospective study on Hepatitis B screening and risk of HBV reactivation in immune checkpoint inhibitor therapy for advanced cancer patients

Htut, Saw, Fletcher, James, Lyle, Megan, Rainey, Natalie, Lui, Andrew and Pandey, Ritwik (2020). Retrospective study on Hepatitis B screening and risk of HBV reactivation in immune checkpoint inhibitor therapy for advanced cancer patients. COSA's 47th Annual Scientific Meeting, Quality and Safety, Implementation Science, Cardio‐Oncology, Virtual, Australia, 11-13 November 2020. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.13498

Retrospective study on Pneumocystis jirovecii Pneumonia (PJP) prophylaxis in advanced cancer patients requiring immunosuppression from immune-related adverse events.

Htut, Saw, Fletcher, James, Lyle, Megan, Rainey, Natalie, Lui, Andrew and Pandey, Ritwik (2020). Retrospective study on Pneumocystis jirovecii Pneumonia (PJP) prophylaxis in advanced cancer patients requiring immunosuppression from immune-related adverse events.. COSA's 47th Annual Scientific Meeting, Quality and Safety, Implementation Science, Cardio‐Oncology, 11–13 November 2020, Virtual, Australia, 11-13 November 2020. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.13498

Corticosteriods use and immunotherapy efficacy in patients with non-small cell lung cancer: experience in a regional cancer center

Hossain, Tasafin, Htut, Saw, Pathmanathan, Shivanshan, Fletcher, James, Pandey, Ritwik, Lui, Andrew, Lyle, Megan and Rainey, Natalie (2020). Corticosteriods use and immunotherapy efficacy in patients with non-small cell lung cancer: experience in a regional cancer center. Medical Oncology Group of Australia Annual Science Meeting 2020, Virtual, Australia, 14 - 21 August 2020. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing . doi: 10.1111/ajco.13417

Do antibiotics reduce survival in patients with advanced non-small cell lung cancer treated with immunotherapy?

Hossain, Tasafin, Htut, Saw, Pathmanathan, Shivanshan, Fletcher, James, Pandey, Ritwik, Lui, Andrew, Lyle, Megan and Rainey, Natalie (2020). Do antibiotics reduce survival in patients with advanced non-small cell lung cancer treated with immunotherapy?. Medical Oncology Group of Australia Annual Scientific Meeting, Virtual, Australia, 14-21 August 2020. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.

Do proton pump inhibitors affect survival in patients with non-small cell lung cancer treated with immune check point inhibitors?

Hossain, Tasafin, Htut, Saw, Pathmanathan, Shivanshan, Fletcher, James, Pandey, Ritwik, Lui, Andrew, Lyle, Megan and Rainey, Natalie (2020). Do proton pump inhibitors affect survival in patients with non-small cell lung cancer treated with immune check point inhibitors?. Medical Oncology Group of Australia Annual Scientific Meeting, Virtual Conference, Australia, 14-21 August 2020. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.

Immunotherapy efficacy and concomitant proton pump inhibitor use in non-small cell lung cancer

Hossain, Tasafin, Htut, Saw, Pathmanathan, Shivanshan, Fletcher, James, Pandey, Ritwik, Lui, Andrew, Lyle, Megan and Rainey, Natalie (2020). Immunotherapy efficacy and concomitant proton pump inhibitor use in non-small cell lung cancer. Medical Oncology Group of Australia Annual Scientific Meeting, Virtual, Australia., 14-21 August 2020. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.

Limited benefit of adjuvant chemotherapy in resected Epidermal Growth Factor Receptor (EGFR) positive non-small cell lung cancer (NSCLC)

O'Leary, Connor, Fletcher, James, Yuile, Alexander, Xu, Wen, Ladwa, Rahul, McGrath, Margaret, Pavlakis, Nick, Hughes, Brett, McCaffery, Elizabeth and O'Byrne, Kenneth (2020). Limited benefit of adjuvant chemotherapy in resected Epidermal Growth Factor Receptor (EGFR) positive non-small cell lung cancer (NSCLC). Medical Oncology Group of Australia Annual Scientific Meeting, Virtual, Australia, 14-21 August 2020. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.

Administration of immune checkpoint inhibitors using teleoncology model of care in Far North Queensland: A multicenter review of safety outcomes

Fletcher, James, Kang, Sebastian, Brown, Amy, Sabesan, Sabe S., Lyle, Megan, Pandey, Ritwik, Lui, Andrew, Rainey, Natalie, Kelly, Barbara, Schmidt, Andrew Lachlan and Joshi, Abhishek Jagdish (2020). Administration of immune checkpoint inhibitors using teleoncology model of care in Far North Queensland: A multicenter review of safety outcomes. 2020 ASCO Annual Meeting, Online, 29 – 31 May 2020. Alexandria, VA United States: American Society of Clinical Oncology (ASCO). doi: 10.1200/jco.2020.38.15_suppl.2084

Administration of immune checkpoint inhibitors using teleoncology model of care in Far North Queensland: A multicenter review of safety outcomes

Fletcher, James, Kang, Sebastian, Brown, Amy, Sabesan, Sabe S., Lyle, Megan, Pandey, Ritwik, Lui, Andrew, Rainey, Natalie, Kelly, Barbara, Schmidt, Andrew Lachlan and Joshi, Abhishek Jagdish (2020). Administration of immune checkpoint inhibitors using teleoncology model of care in Far North Queensland: A multicenter review of safety outcomes. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Electr Network, 29-31 May 2020. Alexandria, VA, United States: American Society of Clinical Oncology.

Mortality within 30 days of receiving checkpoint inhibitor immunotherapy: an Australian multicenter review

Fletcher, James, Kang, Katherine, Smallwood, Gabriella, Sanmugarajah, Jasotha and Lyle, Megan (2020). Mortality within 30 days of receiving checkpoint inhibitor immunotherapy: an Australian multicenter review. 2020 ASCO Annual Meeting, Online, 29-31 May 2020. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2020.38.15_suppl.e19182

Survival outcomes for BRAF wild-type advanced melanoma treated with first line immunotherapy in a regional cancer centre: Experience from the Liz Plummer Cancer Centre

Fletcher, James, Htut, Saw, Kang, Katherine and Lyle, Megan (2019). Survival outcomes for BRAF wild-type advanced melanoma treated with first line immunotherapy in a regional cancer centre: Experience from the Liz Plummer Cancer Centre. COSA's 46th Annual Scientific Meeting, Urological cancer; Age and gender in cancer practice, Adelaide, SA, Australia, 12-14 November 2019. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.

Mortality within 30 days of receiving checkpoint inhibitor immunotherapy in an Australian regional cancer centre

Fletcher, James, Kang, Katherine and Lyle, Megan (2019). Mortality within 30 days of receiving checkpoint inhibitor immunotherapy in an Australian regional cancer centre. COSA's 46th Annual Scientific Meeting, Urological cancer; Age and gender in cancer practice, Adelaide, SA, Australia, 12-14 November 2019. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.13263

A single centre retrospective analysis of immunotherapy outcomes for patients with non-small cell lung cancer (NSCLC)

Fletcher, James, Marukawa, Mutsuki and Pandey, Ritwik (2019). A single centre retrospective analysis of immunotherapy outcomes for patients with non-small cell lung cancer (NSCLC) . COSA's 46th Annual Scientific Meeting, Urological cancer; Age and gender in cancer practice, Adelaide, SA, Australia, 12-14 November 2019. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.

Improving the rate of documented patient consent for systemic therapy at a tertiary cancer care centre: a quality improvement project from the Sunshine Coast University Hospital

Jakobsson, Haakan, Wood, Samuel, Fletcher, James, Azer, Mary, Francesconi, Alessandra, Houston, Kathleen, Long, Jeremy, Manders, Peter, Morris, Michelle, Wilson, Jennifer and Chan, Bryan A. (2018). Improving the rate of documented patient consent for systemic therapy at a tertiary cancer care centre: a quality improvement project from the Sunshine Coast University Hospital. COSA's 45th Annual Scientific Meeting, Mesothelioma and Gastro‐Intestinal Cancers: Technology and Genomics, Perth, WA, Australia, 13 - 15 November 2018. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.

Review of the integrated exercise physiology (EP) clinic at a tertiary cancer centre: experience from the ADEM crosby centre, Sunshine Coast University Hospital (SCUH)

Fletcher, James, Forbes, Curtis, Cooper, Victoria, McAndrew, Alastair, Turner, Cassie and Chan, Bryan A. (2018). Review of the integrated exercise physiology (EP) clinic at a tertiary cancer centre: experience from the ADEM crosby centre, Sunshine Coast University Hospital (SCUH). COSA's 45th Annual Scientific Meeting, Perth, WA, Australia, 13 - 15 November 2018. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.

Assessing Treatment Tolerability after Geriatric Assessment in the Senior Oncology Clinic at the Gold Coast University Hospital

Fletcher, James, Sanmugarajah, Jasotha, Caird, Susan, Allen, Michael, Quennell, Amanda and Powell, Michael (2017). Assessing Treatment Tolerability after Geriatric Assessment in the Senior Oncology Clinic at the Gold Coast University Hospital. COSA's 44th Annual Scientific Meeting, Immunotherapy: Molecules and Mountains, Sydney, NSW Australia, 13–15 November 2017. Richmond, VIC Australia: Wiley-Blackwell.

Retrospective Single Institution Audit of the Tolerability and Efficacy of Enzalutamide in Patients with Castrate Refractory Metastatic Prostate Cancer in a Community Oncology Setting

Fletcher, James, Allan, Suzanne and Hill, Andrew (2017). Retrospective Single Institution Audit of the Tolerability and Efficacy of Enzalutamide in Patients with Castrate Refractory Metastatic Prostate Cancer in a Community Oncology Setting. COSA's 44th Annual Scientific Meeting, Immunotherapy: Molecules and Mountains, Sydney, NSW Australia, 13–15 November 2017. Richmond, VIC Australia: Wiley-Blackwell.